Loading...
Market
What will be the primary application area for OncoGAN's synthetic genomes by October 2025?
2
Resolution / Starting Odds
Cancer research • 25%
Drug development • 25%
Genetic disease research • 25%
Other applications • 25%
Research publications and industry reports
Story
New AI Pipeline OncoGAN Generates Synthetic Cancer Genomes, Addressing Privacy Concerns
Oct 21, 2024, 05:57 AM
A novel AI-based pipeline called OncoGAN has been introduced to generate realistic synthetic cancer genomes using generative adversarial networks (GANs) and tabular variational autoencoders (VAEs). This approach addresses the limitations of real patient genomic data due to privacy concerns. The development of OncoGAN aims to facilitate research in precision oncology by providing high-quality synthetic genomic data for algorithm development and benchmarking.
View original story
Similar markets
Breast Cancer Diagnosis • 25%
Lung Cancer Diagnosis • 25%
Prostate Cancer Diagnosis • 25%
Other • 25%
Therapeutic use in hospitals • 25%
Research tool for labs • 25%
No commercial application • 25%
Other • 25%
Breast Cancer • 25%
Lung Cancer • 25%
Prostate Cancer • 25%
Other • 25%
Treatment of A. baumannii infections • 25%
Treatment of other bacterial infections • 25%
Pandemic preparedness • 25%
Other • 25%
Respiratory infections • 25%
Bloodstream infections • 25%
Gastrointestinal infections • 25%
Other • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
Human gene editing • 25%
Animal models • 25%
Plant genomics • 25%
Microbial engineering • 25%
Drug Development • 25%
Disease Diagnosis • 25%
Biosensor Technology • 25%
Other • 25%
Smartphones • 25%
Data Centers • 25%
AI Models • 25%
Other • 25%
Game Development • 25%
AI Research • 25%
Educational Tools • 25%
Other • 25%
Cancer treatment advancements • 25%
Rare disease understanding • 25%
Regenerative medicine • 25%
Other • 25%
Breast Cancer • 25%
Lung Cancer • 25%
Prostate Cancer • 25%
Other • 25%